3Jensen JU,Heslet L,Jensen TH,et al.Procalcitonin increase in early identification of critically ill patients athigh risk of mortality[J].Crit Care Med,2006,34(10):2596-2602.
9Christ-Crain M,Jaccard-Stolz D,Bingisser R,et al.Effect of procalcitonin guided treatment on antibiotic use and outcome inlower respiratory tract infections:clusterrandomised,singleblindedintervention trial[J].Lancet,2008,363(9409):600-607.
10Mueller C,Huber P,Laifer G,et al.Procalcitonin and the earlydiagnosis of infective endocarditis[J].Circulation,2009,109(14):1707-1710.
3Mirjam Christ-Crain, Beat Miiller. Procalcitonin in bacterial infections-hype, hope, more or less [J]? Swiss Med Wkly, 2005, 135: 451--460.
4Muller B, White JC, Nylen E, et al. Ubiquitous expression of the ealcitortin-1 gene in multiple tissues in response to sepsis [J]. J Clin Endocrinol Metab, 2001, 86: 396-404.
5Philippe Linseheid, Dalma Seboek, Eric S. Nylen, et al. In Vitro and in Vivo Caleitonin I Gene Expression in Parenchymal Cells: A Novel Product of Human Adipose Tissue [J]. Endocrinology, 2003, 144: 5578-5584.
6Meisner M., Procalcitonin (PCT) A new, innovative infection parameter.; Biochemical and clinical aspects; ISBN: 3-13- 105503-0 [S]. Thieme Stuttgart, New York, 2000.
7Mirjam Christ-Crain, Dalana Stolz, Roland Bingisser, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia [J]. American journal of respiratory and critical care medicine, 2006, 174: 84-93.
8Daiana Stolz, Miriam Christ-Crain, Roland Bingisser, et al. Antibiotic Treatment of Exacerbations of COPD [J]. Chest, 2007, 1 : 9-19.
9Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitanin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial [J]. Lancet, 2004, 363: 600-607.
10Jens Ulrik Jensen, Lars Heslet, Tom Hartvig Jensen et al. Procalcitonin increase in early identifucation of critically ill patients at high risk of mortality [J]. Crit care med, 2006, 34: 2596-2602.
